Page 2 - Joseph Stringer News Today

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Biotech stocks make for an interesting study. They represent a high-risk sector, characterized by famously high overhead and long lead times to develop new products. However, they also hold the potential for high rewards when new drugs open up markets with potential sales targets sometimes reaching billions of dollars. It’s not just the future sales potential that fuels the possibilities for rewards; a successful small-cap biotech company, with a newly approved drug, will frequently attra...

Operator: Good morning, and welcome to Ionis First Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.

Operator: Good afternoon. My name is Josh, and I will be your conference facilitator.

MRNA earnings call for the period ending December 31, 2022.

Lexicon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:LXRX) Q3 2022 Earnings Conference Call November 09, 2022 5:00 PM ET Company Participants Mike Kelly – Investor Relations Lonnel Coats – Chief...

Theravance Biopharma, Inc. (NASDAQ:NASDAQ:TBPH) Q3 2022 Earnings Conference Call November 7, 2022 05:00 PM ET Company Participants Rick Winningham – Chairman and Chief Executive Officer...

Rhythm Pharmaceuticals, Inc. (NASDAQ:NASDAQ:RYTM) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants David Connolly - Investor Relations and Corporate...

Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Lavina Talukdar – Head-Investor Relations Stéphane Bancel – Chief...

MRNA earnings call for the period ending September 30, 2022.